On behalf of the organising committee, we warmly welcome you to the Drug Hypersensitivity Symposium 2026 – Challenging Evidence, a meeting that brings together the world’s leading science, new discoveries, and the latest evidence to drive meaningful change in clinical drug allergy practice.

Click here for our EventBrite site.

Convenors

Prof Jason Trubiano
Prof Jason Trubiano
Prof Jason Trubiano is a prominent Professor of Infectious Diseases and a leading expert in antibiotic and drug allergy research based in Melbourne, Australia. He holds several key positions in clinical and academic institutions, including Director of the Department of Infectious Diseases and Immunology at Austin Health and Head of Department of Infectious Diseases at Melbourne Medical School, The University of Melbourne.
Prof Philip Li
Prof Philip Li
Prof Philip Li is a Clinical Assistant Professor of the University of Hong Kong, serving as Division Chief of Rheumatology & Clinical Immunology. He is also President of the Hong Kong Institute of Allergy and Board Director of the Asia Pacific Association of Allergy, Asthma & Clinical Immunology (APAAACI) and secretary of the International Societies Committee of the European Academy of Allergy & Clinical Immunology (EAACI).

Meet our Speakers

DHS2026 Program

Our 2026 Partners